{
    "nctId": "NCT02937779",
    "officialTitle": "Tenofovir As Prevention Of Hepatitis b Mother-to-child Transmission",
    "inclusionCriteria": "* \\>= 18 years old the day of inclusion\n* Pregnancy\n* Positive HBs Ag\n* Informed consent obtained with information sheet given and explained and the consent form signed by the participant of the project investigator at the latest the day of the inclusion\n* Must be FEMALE\n* Must have minimum age of 18 Years\n* Must have maximum age of 50 Years",
    "exclusionCriteria": "* Women refusing HBs Ag test\n* HIV co-infection\n* HCV co-infection\n* HBV treatment ongoing at the day of inclusion\n* Creatinine clearance \\< 30 mL/min\n* Severe gravidic disease present at inclusion involving life threatening to the mother and/or the child\n* Evidence of pre-existing fetal anomalies incompatible with the child's life\n* Imminent child's birth defined as cervix dilatation up to 7 centimeters\n* Intention to deliver in a maternity not linked to the study\n* Any concomitant medical condition that, according to the clinical site investigator would contraindicate participation in the study.\n* Concurrent participation in any other clinical trial without written agreement of the two study teams"
}